transgenic mice

trans·gen·ic mice

Mice that have a piece of foreign DNA integrated into their genome.
References in periodicals archive ?
In this study, the effect of NCL on microRNA (miRNA) expression was evaluated by generating transgenic mice with myocardial overexpression of NCL and by analyzing microarrays of mature and precursor miRNAs from mice.
The study used APP/PS1 mice, which are transgenic mice that express human mutated genes that cause Alzheimer's.
The study used PS1 mice, which are transgenic mice that express human mutated genes that cause Alzheimer's.
Mitochondrial function in the brains of the transgenic mice normalized, as did in the heart.
a leading genome editing company, today announced results from a pre-clinical study in transgenic mice demonstrating dose-dependent, in vivo editing using EDIT-101, Editas Medicines pre-clinical product candidate for the treatment of Leber Congenital Amaurosis type 10 (LCA10).
To gain insights into that question, vCJD/BSE transmission studies in which either humanized overexpressing or knock-in transgenic mice were used have been performed (2,26-30).
In particular, they generated transgenic mice with an increased expression throughout their bodies of one of the most important enzymes for the production of NADPH, namely, glucose-6-phosphate dehydrogenase (or G6PD).
Two batches of transgenic mice were developed by a team from the Arabian Gulf University (AGU), led by College of Graduate Studies dean Dr Mohammed Dahmani Fathallah and senior staff members from the Life Sciences Department and Al Jawhara Centre for Molecular Medicine and Genetic Diseases.
Over a period of nine to 10 months, the team fed 4-month-old Alzheimer's-induced transgenic mice a diet containing 6 or 9% walnuts, which is the equivalent of 1 or 1.
The purpose of this study was to investigate whether repeated electroacupuncture (EA) stimulation would improve cognitive function and the pathological features of AD in amyloid precursor protein (APP)/presenilin 1 (PS1) double transgenic mice.
25 July 2013 - Dutch transgenic mice creator Harbour Antibodies BV said Wednesday it had secured EUR 2.